ArticleCell death & disease2026
Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.
Lanyu Jing et al.PubMed ↗Publisher ↗
No numbers read from the abstract.